Multiple Promoters in the WNK1 Gene: One Controls Expression of a Kidney-Specific Kinase-Defective Isoform

ABSTRACT WNK1 is a serine-threonine kinase, the expression of which is affected in pseudohypoaldosteronism type II, a Mendelian form of arterial hypertension. We characterized human WNK1 transcripts to determine the molecular mechanisms governing WNK1 expression. We report the presence of two promoters generating two WNK1 isoforms with a complete kinase domain. Further variations are achieved by the use of two polyadenylation sites and tissue-specific splicing. We also determined the structure of a kidney-specific isoform regulated by a third promoter and starting at a novel exon. This transcript is kinase defective and has a predominant expression in the kidney compared to the other WNK1 isoforms, with, furthermore, a highly restricted expression profile in the distal convoluted tubule. We confirmed that the ubiquitous and kidney-specific promoters are functional in several cells lines and identified core promoters and regulatory elements. In particular, a strong enhancer element upstream from the kidney-specific exon seems specific to renal epithelial cells. Thus, control of human WNK1 gene expression of kinase-active or -deficient isoforms is mediated predominantly through the use of multiple transcription initiation sites and tissue-specific regulatory elements.

[1]  X. Jeunemaître,et al.  Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutation. , 2003, The American journal of medicine.

[2]  D. Ellison,et al.  WNK kinases regulate thiazide-sensitive Na-Cl cotransport. , 2003, The Journal of clinical investigation.

[3]  B. Rossier.  Negative regulators of sodium transport in the kidney: key factors in understanding salt-sensitive hypertension? , 2003, The Journal of clinical investigation.

[4]  R. Lifton,et al.  WNK1, a kinase mutated in inherited hypertension with hyperkalemia, localizes to diverse Cl−-transporting epithelia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Lifton,et al.  Molecular pathogenesis of inherited hypertension with hyperkalemia: The Na–Cl cotransporter is inhibited by wild-type but not mutant WNK4 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Byung-Hoon Lee,et al.  Regulation of WNK1 by an Autoinhibitory Domain and Autophosphorylation* , 2002, The Journal of Biological Chemistry.

[7]  Christopher J. Lee,et al.  Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. , 2002, Nucleic acids research.

[8]  R. Desnick,et al.  Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype. , 2002, American journal of human genetics.

[9]  T. Hall.  Poly(A) tail synthesis and regulation: recent structural insights. , 2002, Current opinion in structural biology.

[10]  E. Castrén,et al.  Analysis of the human TrkB gene genomic organization reveals novel TrkB isoforms, unusual gene length, and splicing mechanism. , 2002, Biochemical and biophysical research communications.

[11]  Peter Jordan,et al.  WNK kinases, a novel protein kinase subfamily in multi-cellular organisms , 2001, Oncogene.

[12]  Robert J. Unwin,et al.  Human Hypertension Caused by Mutations in WNK Kinases , 2001, Science.

[13]  Wange Lu,et al.  Structure of PAK1 in an Autoinhibited Conformation Reveals a Multistage Activation Switch , 2000, Cell.

[14]  E. Goldsmith,et al.  WNK1, a Novel Mammalian Serine/Threonine Protein Kinase Lacking the Catalytic Lysine in Subdomain II* , 2000, The Journal of Biological Chemistry.

[15]  M. Coptcoat,et al.  PSK, a Novel STE20-like Kinase Derived from Prostatic Carcinoma That Activates the c-Jun N-terminal Kinase Mitogen-activated Protein Kinase Pathway and Regulates Actin Cytoskeletal Organization* , 2000, The Journal of Biological Chemistry.

[16]  M. Sibony,et al.  Enhancement of mRNA in situ hybridization signal by microwave heating. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[17]  M. Vasseur-Cognet,et al.  CCAAT/enhancer binding protein alpha (C/EBP alpha) undifferentiated protein: a developmentally regulated nuclear protein that binds to the C/EBP alpha gene promoter. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Barbacid,et al.  The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain , 1990, Cell.

[19]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[20]  J. Coffin,et al.  Bacterial beta-galactosidase as a marker of Rous sarcoma virus gene expression and replication , 1985, Molecular and cellular biology.

[21]  S. McKnight,et al.  Transcriptional control signals of a eukaryotic protein-coding gene. , 1982, Science.

[22]  X. Jeunemaître,et al.  Familial hyperkalemic hypertension (Gordon syndrome): evidence for phenotypic variability in a study of 7 families. , 2001, Advances in nephrology from the Necker Hospital.